Back to Search Start Over

The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018.

Authors :
Lei Ding
Hongda Zhang
Cong Dai
Aikai Zhang
Fengyuan Yu
Lijie Mi
Yingjie Qi
Min Tang
Source :
Cardiovascular Diabetology. 2/28/2024, Vol. 23 Issue 1, p1-11. 11p. 1 Diagram, 5 Charts, 3 Graphs.
Publication Year :
2024

Abstract

Background The Stress hyperglycemia ratio (SHR) is a novel marker reflecting the true acute hyperglycemia status and is associated with clinical adverse events. The relationship between SHR and mortality in patients with diabetes or prediabetes is still unclear. This study aimed to investigate the predictive value of the SHR for all-cause and cardiovascular mortality in patients with diabetes or prediabetes. Methods This study included 11,160 patients diagnosed with diabetes or prediabetes from the National Health and Nutrition Examination Survey (2005–2018). The study endpoints were all-cause and cardiovascular mortality, and morality data were extracted from the National Death Index (NDI) up to December 31, 2019. Patients were divided into SHR quartiles. Cox proportion hazards regression was applied to determine the prognostic value of SHR. Model 1 was not adjusted for any covariates. Model 2 was adjusted for age, sex, and race. Model 3 was adjusted for age, sex, race, BMI, smoking status, alcohol use, hypertension, CHD, CKD, anemia, and TG. Results During a mean follow-up of 84.9 months, a total of 1538 all-cause deaths and 410 cardiovascular deaths were recorded. Kaplan-Meier survival analysis showed the lowest all-cause mortality incidence was in quartile 3 (P<0.001). Multivariate Cox regression analyses indicated that, compared to the 1st quartile, the 4th quartile was associated with higher all-cause mortality (model 1: HR=0.89, 95% CI 0.74–10.7, P=0.226; model 2: HR=1.24, 95% CI 1.03-1.49, P=0.026; model 3: HR=1.30, 95% CI 1.08–1.57, P=0.006). The 3rd quartile was associated with lower cardiovascular mortality than quartile 1 (model 1: HR=0.47, 95% CI 0.32–0.69, P<0.001; model 2: HR=0.66, 95% CI 0.45–0.96, P=0.032; model 3: HR=0.68, 95% CI 0.46–0.99, P=0.049). There was a U-shaped association between SHR and all-cause mortality and an L-shaped association between SHR and cardiovascular mortality, with inflection points of SHR for poor prognosis of 0.87 and 0.93, respectively. Conclusion SHR is related to all-cause and cardiovascular mortality in patients with diabetes or prediabetes. SHR may have predictive value in those patients. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14752840
Volume :
23
Issue :
1
Database :
Academic Search Index
Journal :
Cardiovascular Diabetology
Publication Type :
Academic Journal
Accession number :
177930541
Full Text :
https://doi.org/10.1186/s12933-024-02172-8